Anna Nikkarinen
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High time for risk-adapted treatment in mantle cell lymphoma.
Journal: The Lancet. Haematology
Published: February 15, 2026
Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma - A case report.
Journal: EJHaem
Published: March 05, 2024
Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma.
Journal: Frontiers in immunology
Published: January 19, 2024
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors.
Journal: British journal of haematology
Published: October 29, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026